Advertisement

Topics

Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics

12:21 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Nanotherapeutics, Inc., a biologics focused contract development and manufacturing organization (CDMO), today announced that Robert J. Hennessey has been appointed Chairman of the Board. Commenting on today’s announce...

Other Sources for this Article

At Nanotherapeutics, Inc.
Dennis Tomisaka, 386-462-9663
Director, BD Special Projects
dtomisaka@nanotherapeutics.com
or
At Rx Communications Group, LLC
Melody A. Carey, 917-322-2571
President and Chief Executive Officer
mcarey@rxir.com

NEXT ARTICLE

More From BioPortfolio on "Robert J. Hennessey Appointed Chairman of the Board of Nanotherapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...